Several of the obligations on manufacturers, such as clinical evaluation or vigilance reporting, that were set out only in the Annexes to Directives 90/385/EEC and 93/42/EEC, should be incorporated into the enacting provisions of this Regulation to facilitate its application.
Recital 29, Regulation (EU) 2017/745
In forcesince 5 Apr 2017
- celex=31990L0385
- celex=31993L0042
- num:eu=1990/385
- num:eu=1993/42